
	MolecularHealth delivers on the promise of personalized, precision medicine. By using advanced proprietary information technologies to sift through terabytes of genetic and molecular test findings in a fraction of the time needed for current manual analysis, MolecularHealth provides doctors and patients with faster, more accurate insights into the role genes play in the progression and treatment of an individual&rsquo;s cancer. MolecularHealth&rsquo;s team of doctors, scientists, IT and business experts&mdash;including founders and executives of LION Bioscience, US Oncology and Novartis&mdash;works in partnership with some of the world&rsquo;s leading healthcare and information technology companies, including the University of Texas MD Anderson Cancer Center, SAP AG, and the U.S. Food and Drug Administration (FDA). The company has locations in The Woodlands, Texas, Boston, Mass. and Heidelberg, Germany.
